Kim Kardashian draws ire from FDA for drug endorsement on Instagram
Kim Kardashian West’s Instagram account is drawing attention, although not the kind she likes.
The Food and Drug Administration sent her a warning letter for a picture she posted in which she’s posing with a morning sickness drug. Not only ddi she fail to disclose the drug’s side effects to her 42.4 million followers, she also broke her own vow to keep her account off-limits to brands.
Kardashian tweeted and posted to Instagram a picture on July 19 of a medication called Diclegis, which boasts it’s the only “FDA approved medicine for treatment of morning sickness.” Since she was so “excited and happy” with it, she wrote on Instagram that she’s “partnering” with them to promote it.
Well, the endorsement didn’t sit well with the FDA proving that even the governmental agency keeps up with the Kardashians, albeit slowly. The agency slammed her for not including risk and side effects information on her Instagram caption in a five-page letter dated Aug. 7.
Kardashian included a (non-clickable) link to a safety webpage, but that wasn’t enough.
“By omitting the risks associated with Diclegis, the social media post misleadingly fails to provide material information about the consequences that may result from the use of the drug and suggests that it is safer than demonstrated,” the FDA said.
The Instagram post has been deleted as of Tuesday afternoon, but the tweet has not.
Diclegis’ maker, Duchesnay, told CNBC that it takes government warnings “very seriously” and admitted that Kardashian’s Instagram post needs to be “in accordance with applicable rules and regulations.” That explains why the Instagram post was deleted.
Now that she has complied with the FDA’s request, her Instagram account is back to favoring selfies over sponsors — for now.
-
Can Snap make it as an AR company?
The real question Snap faces is whether adding AR elements to its platform will help it continue growing in the face of competition and uncertainty.
-
How NFTs could evolve for brands — now that marketers know what they actually are
NFTs are finally growing out of crypto novelty into next-gen loyalty tools. Tyler Moebius, founder and CEO of SmartMedia Technologies, explains where else they can go.
-
The ‘retirement’ of M&M spokescandies raises questions about viral marketing, edgy content
Marketers have mixed feelings and questions about the value of viral, stunt marketing after M&M's "retirement" of its spokescandies.
-
SponsoredHow ad tech is tackling waste by optimizing supply chains
Sponsored by Bidtellect The programmatic and digital advertising industry is well aware of the inefficiencies in buying and selling — from auction duplication and volume bias to multi-integrations and reselling — but how did it get this out of control? How can we fix it? A redundant, multiple-step process to ad delivery has become the norm, […]
-
Why digital clutter is driving brands to rethink the value of newspapers advertising
GE, Equinox, Take 5 Oil and agency TBWA New York are among those investing in newspaper ads to generate social media buzz in an ever-more cluttered digital environment.
-
With TikTok’s growing list of issues, should marketers think twice about the platform?
There is a growing list of issues that TikTok needs to resolve, but marketers seem unfazed and continue to be enthralled by the platform.
